Visual Snow Syndrome

What Is It, Causes, Diagnosis, and More

Author: Lily Guo, MD
Editor: Alyssa Haag, MD
Editor: Emily Miao, MD, PharmD
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Abbey Richard, MSc
Modified: Jan 06, 2025

What is visual snow syndrome?

Visual snow syndrome (VSS) is a rare condition characterized by a persistent visual disturbance marked by the presence of tiny flickering dots that affect the entire visual field, reminiscent of the static on a television screen. The dots can be black and white, colored, or transparent. The term visual snow (VS) was initially introduced by Liu et al. in 1995 when they reported four individuals experiencing these visual disturbances. Visual snow syndrome encompasses the visual and non-visual symptoms that individuals may experience with the condition. The exact prevalence is still unknown, but up to 2.2% of the population could be affected.  
An infographic detailing the background, causes, signs and symptoms, diagnosis, and treatment of visual snow syndrome.

What causes visual snow syndrome?

The underlying pathophysiology of VSS is currently unknown, however, recent studies have shown that VSS may be due to widespread cortical dysfunction and cortical hyperexcitability. Some cases of underlying cerebral disease causing secondary VSS have been reported, which include neoplasms affecting the occipital and temporal brain regions; pineal cysts (i.e., fluid-filled space in the pineal gland); Creutzfeldt–Jakob disease (i.e., degenerative brain disorder); idiopathic intracranial hypertension (i.e., increased pressure within the skull); stroke; and multiple sclerosis (i.e., an autoimmune condition affecting the nervous system). In some cases, systemic infections, seizures, and mild traumatic brain injury were thought to trigger VSS. Some medications have been implicated in VSS including steroids, antidepressants (e.g., citalopram), and isotretinoin. Illicit substances including ecstasy, cannabis, psilocybin, and amphetamines, have been linked to VSS.  

What are the signs and symptoms of visual snow syndrome?

The primary symptom of visual snow syndrome includes a continuous visual disturbance, which can be exacerbated by looking at bright and dark surfaces or looking at a computer screen. Other visual symptoms include entoptic phenomena, which refer to visual disturbances that originate from within the human eye itself. Some examples of entoptic phenomena include floaters (i.e., spots that move across one’s vision); selflight of the eye (i.e., light or colored clouds seen with closed eyes); photopsia (i.e., flash-like visual phenomena with sudden onset and brief duration); and “blue field phenomenon” (i.e., perception of moving fragments against a bright background, such as the sky). Additionally, those with VSS can experience palinopsia, which refers to the continued perception of an object even after it is no longer in the visual field and can appear as if moving objects are leaving a trace behind. Photophobia (i.e., hypersensitivity, discomfort to ambient light) and nyctalopia (i.e., impaired night vision) can also be seen. Some report oculomotor deficits, namely the inability to accommodate or focus objects up close and far away, which may result in a reduction in visual acuity.  

In addition to visual symptoms, those with VSS may experience non-visual symptoms including migraines that can occur in association with the appearance or the aggravation of their VSS. Tinnitus is also common, affecting between 15% to 75% of individuals. Additional symptoms include headaches, irritability, lethargy, and difficulty concentrating. Psychiatric comorbidities such as anxiety and depression can be seen in approximately half of individuals with VSS. Additionally, fibromyalgia, postural orthostatic tachycardia syndrome (POTS), dizziness, balance problems, paresthesia, and tremor have been reported. Factors that worsen VSS include exertion from exercise, caffeine, stress, marijuana, and poor sleep quality. Symptoms of VSS can persist over years, in some cases up to eight years, and often strongly impact the quality of life 

How is visual snow syndrome diagnosed?

Visual snow syndrome is a clinical diagnosis based on individual reports of their visual and non-visual symptoms. A thorough history can be taken which includes the onset of symptoms, history of trauma or illness, illicit drug and medication use, presence of symptoms concerning for seizure, and previous tests or medications tried. A diagnostic criteria published in the International Classification of Headache Disorders 3rd edition defines individuals as having VSS if they experience VS for longer than three months. They also need to have at least two other visual symptoms including photophobia, nyctalopia, palinopsia, and enhanced/excessive entoptic phenomenon.  

Those with VSS may benefit from an ophthalmologic evaluation and a neurological evaluation to rule out underlying causes for visual disturbance including retinal detachment, papilledema, or lesions along the visual pathway. Testing may include a magnetic resonance image (MRI) of the brain, an electroencephalogram (EEG), or visual evoked potentials. An ophthalmologist may use an electroretinogram (ERG), a diagnostic test that measures the electrical activity of the retina in response to a light stimulus; test visual fields; and use optical coherence tomography (OCT) to create pictures of the back of the eye to assess for retinal disease. 

How is visual snow syndrome treated?

There is currently no established treatment for visual snow syndrome. Some non-medical options can be trialed including distraction, using tinted lenses, and watching an internet video called “visual snow relief,” which is a video of TV static. There are limited reports of individuals having partial improvement with the use of oral medications including benzodiazepines (e.g., alprazolam, diazepam), anticonvulsants (e.g., lamotrigine, topiramate, gabapentin, valproic acid), and serotonin and norepinephrine reuptake inhibitors (SNRIs) (e.g., duloxetine, venlafaxine). If VSS is due to a secondary cause, treating the underlying cause can improve symptoms. This includes removal of neoplasms, treating idiopathic intracranial hypertension with medication (e.g., acetazolamide) or shunts, and discontinuation of any offending drugs. Treatment for visual snow syndrome is decided on a case-by-case basis with the help of a healthcare professional.  

What are the most important facts to know about visual snow syndrome?

Visual snow syndrome (VSS) refers to the persistent visual disturbance that resembles the flickering static of a television screen. Causes of VSS are largely unknown, however, it has been associated with trauma, neurological disorders affecting the occipital and temporal brain regions, and certain medications. Symptoms can be visual (e.g., floaters, photopsia, photophobia) and non-visual, such as migraines and tinnitus. Diagnosis of VSS is largely based on clinical presentation. The diagnostic criteria requires the individual to have visual snow for at least three months, along with two other visual symptoms. Additional testing may be performed to rule out underlying pathologies of the eye and the brain. Treatment of VSS is difficult, and may include using tinted lenses, taking oral medications, and treating any underlying causes. Visual snow syndrome is a rare, newer disease and more research is necessary to elucidate the pathogenesis and improve treatment options for those affected.  

References


Eren OE, Schöberl F, Schankin CJ, Straube A. Visual snow syndrome after start of citalopram—Novel insights into underlying pathophysiology. Eur J Clin Pharmacol. (2021) 77:271–2. 10.1007/s00228-020-02996-9 


Fraser CL. Visual snow: Updates on pathology. Current Neurology and Neuroscience Reports. 2022;22(3):209-217. doi:https://doi.org/10.1007/s11910-022-01182-x 


Graber M, Goadsby P, Scutelnic A, Schankin C. Natural course of visual snow syndrome: a long-term follow-up study. Eur J Neurol. (2020) 27:162 (EPR1103). 10.1111/ene.14307 


Han MH, Ciuffreda KJ, Rutner D. Historical, diagnostic, and chromatic treatment in visual snow syndrome: A retrospective analysis. Optometry and Vision Science. 2023;100(5):328-333. doi:https://doi.org/10.1097/opx.0000000000002019 


Klein A, Schankin CJ. Visual snow syndrome as a network disorder: A systematic review. Front Neurol. 2021;12. doi: 10.3389/fneur.2021.724072 


Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology. 1995;45(4):664-668. Doi: https://doi.org/10.1212/wnl.45.4.664 


Mehta DG, Garza I, Robertson CE. Two hundred and forty-eight cases of visual snow: a review of potential inciting events and contributing comorbidities. Cephalalgia. 2021;41(9):1015-1026. Doi: 10.1177/0333102421996355 


Puledda F, Schankin C, Goadsby PJ. Visual snow syndrome: A clinical and phenotypical description of 1,100 cases. Neurology. 2020;94(6):e564-e574. doi:10.1212/WNL.0000000000008909 


Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. “Visual snow” – A disorder distinct from persistent migraine aura. Brain. 2014;137(5):1419-1428. doi:https://doi.org/10.1093/brain/awu050 


van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM. Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without. Eur J Neurol. 2021;28:2631–8. 10.1111/ene.14914